0001654954-22-005218 Sample Contracts

Monopar Therapeutics Inc. Common Stock ($0.001 par value per share) Capital on Demand™ Sales Agreement
Monopar Therapeutics • April 20th, 2022 • Pharmaceutical preparations • New York

Monopar Therapeutics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows:

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.